Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Federation Bio
AddedFeb 17, 2024
UpdatedJun 18, 2026
Federation Bio

Federation Bio

Series A

Federation Bio: Pioneering platforms for disease-targeting curative treatments via the human microbiome.

HQ
South San Francisco, CA, US
Founded
2019
Overview
Compare
Fundraising
Employees
News
Website

Federation Bio is dedicated to developing innovative platforms that harness the human microbiome to create curative treatments for various diseases. The company focuses on leveraging the microbiome's potential to address conditions that traditional therapies may not effectively target. By pioneering new approaches in this field, Federation Bio aims to revolutionize how diseases are treated, offering a novel and potentially transformative solution for patients.

Federation Bio has made significant strides in the biotechnology sector, contributing to the growing understanding and application of microbiome-based therapies. The company's advancements have positioned it as a leader in this emerging field, with a strong emphasis on scientific research and clinical development. Through its groundbreaking work, Federation Bio continues to impact the healthcare industry, pushing the boundaries of what is possible in disease treatment and patient care.

Federation Bio - Similar Companies

Petri Bio logo

Petri Bio

petribio.com

MarvelBiome logo

MarvelBiome

marvelbiome.com

Naked Biome logo

Naked Biome

Microbiome Therapeutics logo

Microbiome Therapeutics

Empire Biotechnologies logo

Empire Biotechnologies

Holobiome logo

Holobiome

holobiome.org

Fortis Biosciences logo

Fortis Biosciences

GenieBiome logo

GenieBiome

BlueTurtleBio Technologies logo

BlueTurtleBio Technologies

blueturtlebio.com

The BioCollective logo

The BioCollective

Boost Biomes logo

Boost Biomes

Felix Biotechnology logo

Felix Biotechnology

HI-Bio logo

HI-Bio

hibio.com

Vulcan Biologics logo

Vulcan Biologics

BioPlx logo

BioPlx

Federation Bio - Quick Facts

Who are Federation Bio's competitors?

Companies similar to Federation Bio include Petri Bio, MarvelBiome, Naked Biome and Microbiome Therapeutics.

When was Federation Bio founded?

Federation Bio was founded in 2019.

Where is Federation Bio's headquarters located?

Federation Bio's headquarters is located in South San Francisco, CA, US.

When was Federation Bio's last funding round?

Federation Bio's most recent funding round was for $50M (USD) in October 2020.

How much has Federation Bio raised to-date?

As of Oct 6, 2020, Federation Bio has raised a total of $50M (USD).

How many employees does Federation Bio have?

Federation Bio has 46 employees as of Feb 4, 2024.

Federation Bio - Classification

Ownership
  • Equity
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Treatments
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 4 more industry codes
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified